CAS: 1086062-66-9 - Omipalisib
Formel:C25H17F2N5O3S
InChl:InChI=1S/C25H17F2N5O3S/c1-35-25-23(32-36(33,34)24-5-3-18(26)12-21(24)27)11-17(13-29-25)15-2-4-22-20(10-15)19(7-8-28-22)16-6-9-30-31-14-16/h2-14,32H,1H3
InChI Key:InChIKey=CGBJSGAELGCMKE-UHFFFAOYSA-N
SMILES:O=S(=O)(NC=1C=C(C=NC1OC)C=2C=CC3=NC=CC(C=4C=NN=CC4)=C3C2)C5=CC=C(F)C=C5F
- Synonyme:
- 2,4-Difluoro-N-[2-methoxy-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl]benzenesulfonamide
- Benzenesulfonamide, 2,4-difluoro-N-[2-methoxy-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl]-
- Gsk 2126458
- Gsk 458
- Gsk2126458
- Omipalisib
Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
---|---|---|---|---|
GSK-2126458 REF: IN-DA008TGQCAS: 1086062-66-9 | 98% | Nachfragen | Do 21 Nov 24 | |
GSK2126458 REF: 7W-GW9665CAS: 1086062-66-9 | - - - | 371,00 €~819,00 € | Fr 29 Nov 24 | |
Omipalisib REF: TM-T1861CAS: 1086062-66-9 | 98% - 99.8% | 62,00 €~417,00 € | Fr 29 Nov 24 | |
GSK 2126458 REF: TR-G797500CAS: 1086062-66-9 | - - - | 116,00 €~206,00 € | Di 03 Dez 24 | |
GSK 2126458 REF: 3D-FD43337CAS: 1086062-66-9 | Min. 98 Area-% | 136,00 €~1.136,00 € | Mo 02 Dez 24 |
GSK-2126458
Ref: IN-DA008TGQ
1mg | 51,00 € | ||
2mg | 59,00 € | ||
5mg | 98,00 € | ||
10mg | 119,00 € | ||
50mg | 240,00 € | ||
100mg | 539,00 € | ||
250mg | Nachfragen |
Ref: 7W-GW9665
1mg | 371,00 € | ||
5mg | 548,00 € | ||
10mg | 819,00 € |
Omipalisib
- Inhibitoren
- Autophagie
- PI3K/Akt/mTOR-Signalgebung
- PI3K
- Mehr Kategorien anzeigen
- mTOR
Ref: TM-T1861
5mg | 62,00 € | ||
10mg | 94,00 € | ||
25mg | 172,00 € | ||
50mg | 272,00 € | ||
100mg | 417,00 € | ||
1mL*10mM (DMSO) | 69,00 € |
GSK 2126458
Kontrolliertes ProduktRef: TR-G797500
1mg | 116,00 € | ||
10mg | 206,00 € |
GSK 2126458
Ref: 3D-FD43337
5mg | 136,00 € | ||
10mg | 217,00 € | ||
25mg | 457,00 € | ||
50mg | 723,00 € | ||
100mg | 1.136,00 € |